Internal Medicine, Hematology & Oncology · Salem, VA
NPI
1578876843
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1900 Electric Rd
Salem, VA, 24153
Phone (540) 774-8660
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.8M
263,033 services
Medicare patients, 2024
941
Average age 75
Drug cost, 2024
$3.7M
2,144 prescriptions
Company payments, 2025
$1,580
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew E Fintel was code J9271 (injection, pembrolizumab, 1 mg), 16,900 times for 17 patients. In total Andrew E Fintel billed 263,033 services in 178 codes, and Medicare paid $4.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-05-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 16,900 | 17 | $44.75 | $756K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 13,845 | 15 | $2.32 | $32K |
| J0185 Injection, aprepitant, 1 mg | Office | 13,650 | 33 | $1.34 | $18K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 3,100 | 30 | $15.79 | $49K |
| 85025 Blood Count | Office | 2,556 | 686 | $7.59 | $19K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,225 | 59 | $0.09 | $197 |
| J0897 Injection, denosumab, 1 mg | Office | 2,160 | 17 | $20.43 | $44K |
| 80053 Clinical Chemistry | Office | 1,900 | 532 | $10.30 | $20K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,763 | 50 | $0.69 | $1,217 |
| 36415 Venipuncture Blood Collection | Office | 1,214 | 531 | $8.63 | $10K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,060 | 26 | $0.24 | $258 |
| 99214 Office E&M - Established | Office | 758 | 375 | $89.27 | $68K |
| 96375 Injection Administration | Office | 756 | 94 | $11.30 | $8,544 |
| 96413 Chemotherapy Administration | Office | 579 | 120 | $96.36 | $56K |
| 99213 Office E&M - Established | Office | 549 | 426 | $58.55 | $32K |
By year: 2022 $3.5M for 225,877 services; 2023 $3.9M for 239,356 services; 2024 $4.8M for 263,033 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,556 | 686 | $7.59 | $19K |
| 80053 Clinical Chemistry | 1,900 | 532 | $10.30 | $20K |
| 36415 Venipuncture Blood Collection | 1,214 | 531 | $8.63 | $10K |
| 82728 Clinical Chemistry | 317 | 169 | $13.24 | $4,198 |
| 83550 Clinical Chemistry | 300 | 164 | $8.49 | $2,547 |
| 83540 Clinical Chemistry | 300 | 164 | $6.28 | $1,884 |
| 82784 Immunoassay | 285 | 38 | $9.11 | $2,597 |
| 84443 Clinical Chemistry | 282 | 61 | $16.40 | $4,625 |
| 84480 Clinical Chemistry | 241 | 44 | $13.90 | $3,350 |
| 82378 Clinical Chemistry | 227 | 79 | $18.58 | $4,218 |
Medicare prescription drug claims, 2024
In 2024, the drug Andrew E Fintel prescribed most often to Medicare patients was Letrozole, with 193 prescriptions and refills. In total Andrew E Fintel wrote 2,144 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 193 | 387 | 41 | $3,347 |
| Eliquis Apixaban | 142 | 164 | 26 | $94K |
| Prednisone Generic | 121 | 128 | 37 | $461 |
| Olanzapine Generic | 108 | 136 | 46 | $1,717 |
| Dexamethasone Generic | 106 | 107 | 41 | $2,271 |
| Anastrozole Generic | 90 | 193 | 28 | $1,333 |
| Tamoxifen Citrate Generic | 80 | 180 | 23 | $1,926 |
| Hydroxyurea Generic | 79 | 133 | 18 | $1,073 |
| Potassium Chloride Generic | 68 | 74 | 19 | $510 |
| Acyclovir Generic | 62 | 74 | 17 | $483 |
| Lenalidomide Generic | 52 | 52 | Under 11 | $866K |
| Gabapentin Generic | 50 | 62 | 21 | $316 |
| Warfarin Sodium Generic | 39 | 55 | Under 11 | $75.87 |
| Allopurinol Generic | 38 | 42 | 11 | $208 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 37 | 37 | 24 | $434 |
Brand drugs: 342 claims; generic drugs: 1,802 claims; opioid claims: 87.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew E Fintel $1,580 ($1,580 in general payments such as food, travel and fees) from 15 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,100.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 14 | $1,100 |
| Pfizer Inc. PFE | 3 | $68.17 |
| Abbvie Inc. ABBV | 3 | $66.79 |
| Daiichi Sankyo Inc. 4568.T | 2 | $47.65 |
| Accord Healthcare, Inc. | 2 | $44.91 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $41.56 |
| Janssen Biotech, Inc. JNJ | 1 | $37.82 |
| Adaptive Biotechnologies Corporation ADPT | 1 | $31.82 |
| Astellas Pharma US Inc 4503.T | 1 | $27.99 |
| Servier Pharmaceuticals LLC | 1 | $23.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.